Status:
UNKNOWN
Conditioned Pain Modulation in Chronic Neck Pain Patients
Lead Sponsor:
Peking University People's Hospital
Conditions:
Neck Pain
Eligibility:
All Genders
21-80 years
Brief Summary
The aim of this study was to evaluate changes in local and segmental hypersensitivity and endogenous pain inhibition in people with chronic nonspecific neck pain.
Detailed Description
Quantitative sensory testing is widely used in human research to investigate the state of the peripheral and central nervous system contributions in pain processing. It is a valuable tool to help iden...
Eligibility Criteria
Inclusion
- Chronic neck pain subjects
- Inclusion criteria:
- Age 21-80 years old.
- People must have experienced neck pain for at least 3 months and have reported a minimal pain level of 30 (pain threshold) on the 0-100 pain numerical rating scale (NRS) in the last 7 days.
- Exclusion Criteria:
- Age under 21 or over 80.
- Patients were excluded if they had taken pain medications on the day of the assessment or if they had serious spinal pathologies, such as fractures, tumors or inflammatory diseases, such as ankylosing spondylitis, nerve root compromise confirmed by clinical neurological tests or severe cardiorespiratory diseases.
- Those who were pregnant, patients with cancer and those with a cardiac pacemaker were also excluded.
- Healthy volunteers
- Inclusion criteria:
- Age 21-80 years old.
- These participants must not have presented episodes of low back pain for more than 7 days in the last 12 months.
- Exclusion Criteria:
- Age below 21 or over 80 years old.
- These participants have presented episodes of low back pain for more than 7 days in the last 12 months.
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03362203
Start Date
January 1 2018
End Date
August 1 2018
Last Update
December 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, China, 100044